Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

1.

Polypharmacy for schizophrenia.

Ballon J, Stroup TS.

Curr Opin Psychiatry. 2013 Mar;26(2):208-13. doi: 10.1097/YCO.0b013e32835d9efb. Review.

PMID:
23318662
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.

Kulkarni J, Filia S, Berk L, Filia K, Dodd S, de Castella A, Brnabic AJ, Lowry AJ, Kelin K, Montgomery W, Fitzgerald PB, Berk M.

BMC Psychiatry. 2012 Dec 17;12:228. doi: 10.1186/1471-244X-12-228.

PMID:
23244301
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Drug-drug conditioning between citalopram and haloperidol or olanzapine in a conditioned avoidance response model: implications for polypharmacy in schizophrenia.

Sparkman NL, Li M.

Behav Pharmacol. 2012 Oct;23(7):658-68. doi: 10.1097/FBP.0b013e328358590d.

PMID:
22903071
[PubMed - indexed for MEDLINE]
4.

Antipsychotic monotherapy and polypharmacy in the treatment of outpatients with schizophrenia in the European Schizophrenia Outpatient Health Outcomes Study.

Novick D, Ascher-Svanum H, Brugnoli R, Bertsch J, Hong J, Haro JM.

J Nerv Ment Dis. 2012 Jul;200(7):637-43. doi: 10.1097/NMD.0b013e31825bfd95.

PMID:
22759944
[PubMed - indexed for MEDLINE]
5.

Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia.

Tiihonen J, Suokas JT, Suvisaari JM, Haukka J, Korhonen P.

Arch Gen Psychiatry. 2012 May;69(5):476-83. doi: 10.1001/archgenpsychiatry.2011.1532.

PMID:
22566579
[PubMed - indexed for MEDLINE]
6.

A case of quetiapine XR and divalproex-associated neutropenia followed by successful use of ziprasidone.

Estabrook KR, Pheister M.

J Clin Psychopharmacol. 2012 Jun;32(3):417-8. doi: 10.1097/JCP.0b013e318253a071. No abstract available.

PMID:
22561473
[PubMed - indexed for MEDLINE]
7.

Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment.

Längle G, Steinert T, Weiser P, Schepp W, Jaeger S, Pfiffner C, Frasch K, Eschweiler GW, Messer T, Croissant D, Becker T, Kilian R.

Acta Psychiatr Scand. 2012 May;125(5):372-81. doi: 10.1111/j.1600-0447.2012.01835.x. Epub 2012 Feb 9.

PMID:
22321029
[PubMed - indexed for MEDLINE]
8.

Psychotropic drug and polypharmacy use among adolescents and young adults: findings from the Finnish 1981 Nationwide Birth Cohort Study.

Gyllenberg D, Sourander A.

Nord J Psychiatry. 2012 Oct;66(5):336-42. Epub 2012 Jan 3.

PMID:
22212103
[PubMed - indexed for MEDLINE]
9.

Identification and management of in-hospital drug-induced delirium in older patients.

Catic AG.

Drugs Aging. 2011 Sep 1;28(9):737-48. doi: 10.2165/11592240-000000000-00000. Review.

PMID:
21913739
[PubMed - indexed for MEDLINE]
10.

How the medication review can help to reduce risk of falls in older patients.

Kelly DM, Frick EM, Hale LS.

JAAPA. 2011 Apr;24(4):30-4, 55. Review. No abstract available.

PMID:
21534380
[PubMed - indexed for MEDLINE]
11.
12.

[Polypharmacy in schizophrenia].

Zink M, Englisch S, Meyer-Lindenberg A.

Nervenarzt. 2011 Jul;82(7):853-8. doi: 10.1007/s00115-010-3196-0. German.

PMID:
21165589
[PubMed - indexed for MEDLINE]
13.

A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines.

Pascual JC, Martín-Blanco A, Soler J, Ferrer A, Tiana T, Alvarez E, Pérez V.

Int Clin Psychopharmacol. 2010 Nov;25(6):349-55. doi: 10.1097/YIC.0b013e32833e23ed.

PMID:
20838221
[PubMed - indexed for MEDLINE]
14.

Validity of the Finnish Prescription Register for measuring psychotropic drug exposures among elderly finns: a population-based intervention study.

Rikala M, Hartikainen S, Sulkava R, Korhonen MJ.

Drugs Aging. 2010 Apr 1;27(4):337-49. doi: 10.2165/11315960-000000000-00000.

PMID:
20359263
[PubMed - indexed for MEDLINE]
15.

Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study.

Molina JD, Lerma-Carrillo I, Leonor M, Pascual F, Blasco-Fontecilla H, González-Parra S, López-Muñoz F, Alamo C.

Clin Neuropharmacol. 2009 Jan-Feb;32(1):10-5. doi: 10.1097/WNF.0B013E3181672213.

PMID:
18978498
[PubMed - indexed for MEDLINE]
16.

Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study.

Taylor M, Shajahan P, Lawrie SM.

J Clin Psychiatry. 2008 Feb;69(2):240-5.

PMID:
18363452
[PubMed - indexed for MEDLINE]
17.

Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy.

Vucicevic Z, Degoricija V, Alfirevic Z, Vukicevic-Badouin D.

Int J Clin Pharmacol Ther. 2007 May;45(5):289-92.

PMID:
17542351
[PubMed - indexed for MEDLINE]
18.

Somatic augmentation strategies in clozapine resistance--what facts?

Tranulis C, Mouaffak F, Chouchana L, Stip E, Gourevitch R, Poirier MF, Olié JP, Lôo H, Gourion D.

Clin Neuropharmacol. 2006 Jan-Feb;29(1):34-44. Review.

PMID:
16518133
[PubMed - indexed for MEDLINE]
19.

Inappropriate medication use in the elderly.

Chutka DS, Takahashi PY, Hoel RW.

Essent Psychopharmacol. 2005;6(6):331-40. Review.

PMID:
16459756
[PubMed - indexed for MEDLINE]
20.

Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.

Kapur S, Remington G.

Biol Psychiatry. 2001 Dec 1;50(11):873-83. Review.

PMID:
11743942
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk